Corning Life Sciences Revenue and Competitors
Estimated Revenue & Valuation
- Corning Life Sciences's estimated annual revenue is currently $43.2M per year.
- Corning Life Sciences's estimated revenue per employee is $155,000
Employee Data
- Corning Life Sciences has 279 Employees.
Corning Life Sciences's People
Name | Title | Email/Phone |
---|
Corning Life Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is Corning Life Sciences?
Corning Life Sciences has been a leading developer, manufacturer and global supplier of scientific laboratory products for more than 90 years.
keywords:N/AN/A
Total Funding
279
Number of Employees
$43.2M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Corning Life Sciences News
2022-04-13 - 2022 Scientists' Choice Awards for Life Sciences winners
Beckman Coulter Life Sciences, Zymo Research, and Corning Life Sciences among those recognized at AACR 2022. 12 Apr 2022. AddThis Sharing Buttons.
2022-04-06 - Discovery Life Sciences to Acquire Gentest Business from ...
"We are excited to welcome the brilliant scientific experts and exceptional talent behind Corning's Gentest portfolio to the Discovery team,"...
2022-03-30 - Global Labware Market Outlook & Forecast Report 2022-2027 ...
... Forecast Report 2022-2027 Featuring Prominent Vendors - Corning, DWK Life Sciences, Bellco Glass, Thermo Fisher Scientific, & Sartorius.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $76.7M | 279 | 1% | N/A |
#2 | $67.5M | 279 | -2% | N/A |
#3 | $75.5M | 279 | 0% | N/A |
#4 | $62.9M | 279 | 0% | N/A |
#5 | $101.3M | 279 | -4% | N/A |